1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Point-of-Care Diagnostic Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Point-of-Care Diagnostic Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Point-of-Care Diagnostic Market Regional Analysis
6.2 Asia Pacific Point-of-Care Diagnostic Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Point-of-Care Diagnostic Market Forecast Analysis
7. Asia Pacific Point-of-Care Diagnostic Market Analysis – by Application
7.1 Infectious Diseases
- 7.1.1 Overview
- 7.1.2 Infectious Diseases: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Cardiac Markers
- 7.2.1 Overview
- 7.2.2 Cardiac Markers: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Oncology Markers
- 7.3.1 Overview
- 7.3.2 Oncology Markers: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 OTC Diagnostic Tests
- 7.4.1 Overview
- 7.4.2 OTC Diagnostic Tests: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Drugs of Abuse
- 7.5.1 Overview
- 7.5.2 Drugs of Abuse: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.6 Blood Gas Testing
- 7.6.1 Overview
- 7.6.2 Blood Gas Testing: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.7 Fertility Testing
- 7.7.1 Overview
- 7.7.2 Fertility Testing: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.8 Urinalysis
- 7.8.1 Overview
- 7.8.2 Urinalysis: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.9 Coagulation
- 7.9.1 Overview
- 7.9.2 Coagulation: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.10 Hematology
- 7.10.1 Overview
- 7.10.2 Hematology: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.11 Glucose Monitoring
- 7.11.1 Overview
- 7.11.2 Glucose Monitoring: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.12 Ambulatory Chemistry
- 7.12.1 Overview
- 7.12.2 Ambulatory Chemistry: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.13 Decentralized Clinical Chemistry
- 7.13.1 Overview
- 7.13.2 Decentralized Clinical Chemistry: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.14 Other Application
- 7.14.1 Overview
- 7.14.2 Other Application: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Asia Pacific Point-of-Care Diagnostic Market Analysis – by End User
8.1 Professional Diagnostic Centers
- 8.1.1 Overview
- 8.1.2 Professional Diagnostic Centers: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Home Care
- 8.2.1 Overview
- 8.2.2 Home Care: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Research Laboratories
- 8.3.1 Overview
- 8.3.2 Research Laboratories: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 End-Users
- 8.4.1 Overview
- 8.4.2 End-Users: Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Asia Pacific Point-of-Care Diagnostic Market – Asia-Pacific Analysis
9.1 Overview
9.2 Asia-Pacific
- 9.2.1 Asia Pacific Point-of-Care Diagnostic Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 Asia Pacific Point-of-Care Diagnostic Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 China:
Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 China: Asia Pacific Point-of-Care Diagnostic Market Breakdown, by Application
- 9.2.1.1.2 China: Asia Pacific Point-of-Care Diagnostic Market Breakdown, by End User
- 9.2.1.2 India:
Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 India: Asia Pacific Point-of-Care Diagnostic Market Breakdown, by Application
- 9.2.1.2.2 India: Asia Pacific Point-of-Care Diagnostic Market Breakdown, by End User
- 9.2.1.3 Japan:
Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Japan: Asia Pacific Point-of-Care Diagnostic Market Breakdown, by Application
- 9.2.1.3.2 Japan: Asia Pacific Point-of-Care Diagnostic Market Breakdown, by End User
- 9.2.1.4 Australia:
Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Australia: Asia Pacific Point-of-Care Diagnostic Market Breakdown, by Application
- 9.2.1.4.2 Australia: Asia Pacific Point-of-Care Diagnostic Market Breakdown, by End User
- 9.2.1.5 Rest of Asia-Pacific :
Asia Pacific Point-of-Care Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Point-of-Care Diagnostic Market Breakdown, by Application
- 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Point-of-Care Diagnostic Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 F. HOFFMANN-LA ROCHE LTD.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Danaher Corporation
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 BIO-RAD LABORATORIES INC.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Abbott Laboratories
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Siemens AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Becton, Dickinson, and Company (BD)
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Nova Biomedical Corporation
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Talis Biomedical Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Quidel Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Chembio Diagnostics, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Asia Pacific Point-of-Care Diagnostic Market
